Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas - PubMed (original) (raw)
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas
Huamin Wang et al. Lab Invest. 2004 Aug.
Free article
Abstract
Loss of phosphatase and tensin homolog (PTEN) and amplification of the epidermal growth factor receptor (EGFR) gene contribute to the progression of gliomas. As downstream targets of the PTEN and EGFR signaling pathways, Akt, NFkappaB, and signal transducer and activator of transcription-3 (Stat3) have been shown to play important roles in the control of cell proliferation, apoptosis, and oncogenesis. We examined the activation status of Akt, NFkappaB, and Stat3 in 259 diffuse gliomas using tissue microarrays and immunohistochemistry, and evaluated their association with glioma grade. We observed significant positive correlations between the activation status of Akt and NFkappaB and glioma grade. In contrast, only focal immunoreactivity for phospho-Stat3 was observed in < 9% of high-grade gliomas. In addition, we observed a significant correlation between the activation of Akt and NFkappaB. Functional correlation between Akt activation and the activation of NFkappaB was confirmed in U251MG GBM cells in which inhibition of Akt activation either by stable expression of PTEN or by the PI3-kinase inhibitors, wortmannin and LY294002, led to a concomitant decrease in NFkappaB-binding activity. Thus, our results demonstrate that constitutive activation of Akt and NFkappaB, but not Stat3, contributes significantly to the progression of diffuse gliomas, and activation of Akt may lead to NFkappaB activation in high-grade gliomas.
Similar articles
- ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
Sinha S, Ghildiyal R, Mehta VS, Sen E. Sinha S, et al. Cell Death Dis. 2013 May 2;4(5):e615. doi: 10.1038/cddis.2013.128. Cell Death Dis. 2013. PMID: 23640457 Free PMC article. - Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D. Haas-Kogan DA, et al. J Natl Cancer Inst. 2005 Jun 15;97(12):880-7. doi: 10.1093/jnci/dji161. J Natl Cancer Inst. 2005. PMID: 15956649 Clinical Trial. - Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Pianetti S, et al. Oncogene. 2001 Mar 15;20(11):1287-99. doi: 10.1038/sj.onc.1204257. Oncogene. 2001. PMID: 11313873 - Pten signaling in gliomas.
Knobbe CB, Merlo A, Reifenberger G. Knobbe CB, et al. Neuro Oncol. 2002 Jul;4(3):196-211. Neuro Oncol. 2002. PMID: 12084351 Free PMC article. Review. - Putting the rap on Akt.
Thompson JE, Thompson CB. Thompson JE, et al. J Clin Oncol. 2004 Oct 15;22(20):4217-26. doi: 10.1200/JCO.2004.01.103. J Clin Oncol. 2004. PMID: 15483033 Review.
Cited by
- TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, Li G, Thorsen F, Huang B, Li X, Wang J. Ji J, et al. Cell Death Differ. 2021 Jan;28(1):367-381. doi: 10.1038/s41418-020-00606-w. Epub 2020 Aug 19. Cell Death Differ. 2021. PMID: 32814880 Free PMC article. - Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.
Krakstad C, Chekenya M. Krakstad C, et al. Mol Cancer. 2010 Jun 1;9:135. doi: 10.1186/1476-4598-9-135. Mol Cancer. 2010. PMID: 20515495 Free PMC article. Review. - Advances in the roles of glycyrrhizic acid in cancer therapy.
Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J, Zeng X, Li L. Zhang Y, et al. Front Pharmacol. 2023 Aug 15;14:1265172. doi: 10.3389/fphar.2023.1265172. eCollection 2023. Front Pharmacol. 2023. PMID: 37649893 Free PMC article. Review. - Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, Levy DE, Depinho RA, Bonni A. de la Iglesia N, et al. Genes Dev. 2008 Feb 15;22(4):449-62. doi: 10.1101/gad.1606508. Epub 2008 Feb 7. Genes Dev. 2008. PMID: 18258752 Free PMC article. - Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
Valdés-Rives SA, González-Arenas A. Valdés-Rives SA, et al. Mediators Inflamm. 2017;2017:9173090. doi: 10.1155/2017/9173090. Epub 2017 Dec 21. Mediators Inflamm. 2017. PMID: 29430083 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous